337 related articles for article (PubMed ID: 26905901)
1. The impact of treatment condition and the lagged effects of PTSD symptom severity and alcohol use on changes in alcohol craving.
Kaczkurkin AN; Asnaani A; Alpert E; Foa EB
Behav Res Ther; 2016 Apr; 79():7-14. PubMed ID: 26905901
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of symptom reduction in a combined treatment for comorbid posttraumatic stress disorder and alcohol dependence.
McLean CP; Su YJ; Foa EB
J Consult Clin Psychol; 2015 Jun; 83(3):655-61. PubMed ID: 26009787
[TBL] [Abstract][Full Text] [Related]
3. Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: a randomized clinical trial.
Foa EB; Yusko DA; McLean CP; Suvak MK; Bux DA; Oslin D; O'Brien CP; Imms P; Riggs DS; Volpicelli J
JAMA; 2013 Aug; 310(5):488-95. PubMed ID: 23925619
[TBL] [Abstract][Full Text] [Related]
4. Changes in coping behavior in a randomized controlled trial of concurrent treatment for PTSD and alcohol dependence.
Zang Y; Yu J; Chazin D; Asnaani A; Zandberg LJ; Foa EB
Behav Res Ther; 2017 Mar; 90():9-15. PubMed ID: 27930926
[TBL] [Abstract][Full Text] [Related]
5. Concurrent treatment of posttraumatic stress disorder and alcohol dependence: Predictors and moderators of outcome.
Zandberg LJ; Rosenfield D; McLean CP; Powers MB; Asnaani A; Foa EB
J Consult Clin Psychol; 2016 Jan; 84(1):43-56. PubMed ID: 26460570
[TBL] [Abstract][Full Text] [Related]
6. Predictors of dropout in concurrent treatment of posttraumatic stress disorder and alcohol dependence: Rate of improvement matters.
Zandberg LJ; Rosenfield D; Alpert E; McLean CP; Foa EB
Behav Res Ther; 2016 May; 80():1-9. PubMed ID: 26972745
[TBL] [Abstract][Full Text] [Related]
7. Posttraumatic stress disorder and alcohol dependence: does order of onset make a difference?
McLean CP; Su YJ; Foa EB
J Anxiety Disord; 2014 Dec; 28(8):894-901. PubMed ID: 25445079
[TBL] [Abstract][Full Text] [Related]
8. Habituation of distress and craving during treatment as predictors of change in PTSD symptoms and substance use severity.
Badour CL; Flanagan JC; Gros DF; Killeen T; Pericot-Valverde I; Korte KJ; Allan NP; Back SE
J Consult Clin Psychol; 2017 Mar; 85(3):274-281. PubMed ID: 28221062
[TBL] [Abstract][Full Text] [Related]
9. Adults with Comorbid Posttraumatic Stress Disorder, Alcohol Use Disorder, and Opioid Use Disorder: The Effectiveness of Modified Prolonged Exposure.
Peck KR; Schumacher JA; Stasiewicz PR; Coffey SF
J Trauma Stress; 2018 Jun; 31(3):373-382. PubMed ID: 29786898
[TBL] [Abstract][Full Text] [Related]
10. The Effects of Prolonged Exposure on Substance Use in Patients With Posttraumatic Stress Disorder and Substance Use Disorders.
Peirce JM; Schacht RL; Brooner RK
J Trauma Stress; 2020 Aug; 33(4):465-476. PubMed ID: 32598569
[TBL] [Abstract][Full Text] [Related]
11. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: A randomized clinical trial in military veterans.
Back SE; Killeen T; Badour CL; Flanagan JC; Allan NP; Ana ES; Lozano B; Korte KJ; Foa EB; Brady KT
Addict Behav; 2019 Mar; 90():369-377. PubMed ID: 30529244
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Integrated Exposure Therapy vs Integrated Coping Skills Therapy for Comorbid Posttraumatic Stress Disorder and Alcohol Use Disorder: A Randomized Clinical Trial.
Norman SB; Trim R; Haller M; Davis BC; Myers US; Colvonen PJ; Blanes E; Lyons R; Siegel EY; Angkaw AC; Norman GJ; Mayes T
JAMA Psychiatry; 2019 Aug; 76(8):791-799. PubMed ID: 31017639
[TBL] [Abstract][Full Text] [Related]
13. A pilot trial of prazosin, an alpha-1 adrenergic antagonist, for comorbid alcohol dependence and posttraumatic stress disorder.
Simpson TL; Malte CA; Dietel B; Tell D; Pocock I; Lyons R; Varon D; Raskind M; Saxon AJ
Alcohol Clin Exp Res; 2015 May; 39(5):808-17. PubMed ID: 25827659
[TBL] [Abstract][Full Text] [Related]
14. Integrated exposure-based therapy for co-occurring posttraumatic stress disorder and substance dependence: a randomized controlled trial.
Mills KL; Teesson M; Back SE; Brady KT; Baker AL; Hopwood S; Sannibale C; Barrett EL; Merz S; Rosenfeld J; Ewer PL
JAMA; 2012 Aug; 308(7):690-9. PubMed ID: 22893166
[TBL] [Abstract][Full Text] [Related]
15. Prolonged exposure vs eye movement desensitization and reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder: a randomized clinical trial.
van den Berg DP; de Bont PA; van der Vleugel BM; de Roos C; de Jongh A; Van Minnen A; van der Gaag M
JAMA Psychiatry; 2015 Mar; 72(3):259-67. PubMed ID: 25607833
[TBL] [Abstract][Full Text] [Related]
16. Naltrexone and disulfiram in patients with alcohol dependence and comorbid post-traumatic stress disorder.
Petrakis IL; Poling J; Levinson C; Nich C; Carroll K; Ralevski E; Rounsaville B
Biol Psychiatry; 2006 Oct; 60(7):777-83. PubMed ID: 17008146
[TBL] [Abstract][Full Text] [Related]
17. Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure (COPE): A Pilot Study in Alcohol-dependent Women.
Persson A; Back SE; Killeen TK; Brady KT; Schwandt ML; Heilig M; Magnusson Å
J Addict Med; 2017; 11(2):119-125. PubMed ID: 28079572
[TBL] [Abstract][Full Text] [Related]
18. A Double-Blind, Randomized, Controlled Pilot Trial of N-Acetylcysteine in Veterans With Posttraumatic Stress Disorder and Substance Use Disorders.
Back SE; McCauley JL; Korte KJ; Gros DF; Leavitt V; Gray KM; Hamner MB; DeSantis SM; Malcolm R; Brady KT; Kalivas PW
J Clin Psychiatry; 2016 Nov; 77(11):e1439-e1446. PubMed ID: 27736051
[TBL] [Abstract][Full Text] [Related]
19. Concurrent Treatment with Prolonged Exposure for Co-Occurring Full or Subthreshold Posttraumatic Stress Disorder and Substance Use Disorders: A Randomized Clinical Trial.
Ruglass LM; Lopez-Castro T; Papini S; Killeen T; Back SE; Hien DA
Psychother Psychosom; 2017; 86(3):150-161. PubMed ID: 28490022
[TBL] [Abstract][Full Text] [Related]
20. Cortisol augmentation of a psychological treatment for warfighters with posttraumatic stress disorder: Randomized trial showing improved treatment retention and outcome.
Yehuda R; Bierer LM; Pratchett LC; Lehrner A; Koch EC; Van Manen JA; Flory JD; Makotkine I; Hildebrandt T
Psychoneuroendocrinology; 2015 Jan; 51():589-97. PubMed ID: 25212409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
